Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study-Reference-Cited by-同舟云学术

Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study

Published:2021 Issue: Volume: Page:
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Yamashita Shizuya¹²,Masuda Daisaku¹,Harada-Shiba Mariko³,Arai Hidenori⁴,Bujo Hideaki⁵,Ishibashi Shun⁶,Daida Hiroyuki⁷,Koga Nobuhiko⁸,Oikawa Shinichi⁹,

Affiliation:

1. Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine

2. Department of Community Medicine, Osaka University Graduate School of Medicine

3. Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute

4. The National Center for Geriatrics and Gerontology

5. Department of Clinical Laboratory and Experimental Research Medicine, Toho University, Sakura Medical Center

6. Division of Endocrinology and Metabolism, Department of Medicine, Jichi Medical University

7. Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine

8. Shin Koga Hospital

9. Diabetes and Lifestyle-related Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association (JATA)

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/advpub/0/advpub_62764/_pdf

Reference50 articles.

1. 1) Goldstein JK, Hobbs HH, Brown MS: Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds), The Metabolic & Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2001. p. 2863-2913

2. 2) Khera AV, Won H-H, Peloso GM, Lawson KS, Bartz TM, Deng X, van Leeuwen EM, Natarajan P, Emdin CA, Bick AG, Morrison AC, Brody JA, Gupta N, Nomura A, Kessler T, Duga S, Bis JC, van Duijn CM, Cupples LA, Psaty B, Rader DJ, Danesh J, Schunkert H, McPherson R, Farrall M, Watkins H, Lander E, Wilson JG, Correa A, Boerwinkle E, Merlini PA, Ardissino D, Saleheen D, Gabriel S, Kathiresan S: Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia. J Am Coll Cardiol, 2016; 67: 2578-2589

3. 3) Garcia CK, Wilund K, Arca M, Zuliani G, Fellin R, Maioli M, Calandra S, Bertolini S, Cossu F, Grishin N, Barnes R, Cohen JC, Hobbs HH: Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science, 2001; 292: 1394-1398

4. 4) Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG: Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab, 2012; 97: 3956-3964

5. 5) Austin MA, Hutter CM, Zimmern RL, Humphries SE: Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol, 2004; 160: 407-420

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy, Safety, and Pharmacokinetics of Inclisiran in Japanese Patients: Results from ORION-15;Journal of Atherosclerosis and Thrombosis;2024-06-01

2. Physical signs and atherosclerotic cardiovascular disease in familial hypercholesterolemia: the HELLAS-FH Registry;Journal of Cardiovascular Medicine;2024-03-20

3. Familial hypercholesterolemia with special focus on Japan;Clinica Chimica Acta;2024-03

4. Risk Assessment for Cardiovascular Events using Achilles Tendon Thickness and Softness and Intima-Media Thickness in Familial Hypercholesterolemia;Journal of Atherosclerosis and Thrombosis;2024

5. A Medical Claims Database Study of Factors Associated with Medication Adherence and Treatment Persistence in Patients Receiving PCSK9 Monoclonal Antibodies;Journal of Atherosclerosis and Thrombosis;2024